Genomic Alterations and Outcomes with VEGF-Targeted Therapy in Patients with Clear Cell Renal Cell Carcinoma

Background: Mutations in VHL, PBRM1, SETD2, BAP1, and KDM5C are common in clear cell renal cell carcinoma (ccRCC), and presence of certain mutations has been associated with outcomes in patients with non-metastatic disease. Limited information is available regarding the correlation between genomic a...

Descripción completa

Detalles Bibliográficos
Autores principales: Carlo, M.I., Manley, B., Patil, S., Woo, K.M., Coskey, D.T., Redzematovic, A., Arcila, M., Ladanyi, M., Lee, W., Chen, Y.B., Lee, C.H., Feldman, D.R., Hakimi, A.A., Motzer, R.J., Hsieh, J.J., Voss, M.H.
Formato: Online Artículo Texto
Lenguaje:English
Publicado: IOS Press 2017
Materias:
Research Report
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6179122/
https://www.ncbi.nlm.nih.gov/pubmed/30334004
http://dx.doi.org/10.3233/KCA-160003

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6179122/
https://www.ncbi.nlm.nih.gov/pubmed/30334004
http://dx.doi.org/10.3233/KCA-160003

Ejemplares similares